Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design

BACKGROUND: Many patients with asthma experience loss of lung function over time, and in certain patients this can lead to progressive obstructive patterns similar to COPD. Patients with severe asthma may experience accelerated lung function decline (LFD). However, characteristics and risk factors f...

Descripción completa

Detalles Bibliográficos
Autores principales: De Prado Gomez, Lucia, Pavord, Ian, Busse, William, Brightling, Christopher E., Wechsler, Michael E., Rabe, Klaus F., Zhang, Mei, Xing, Jun, Jacob-Nara, Juby A., Rowe, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Study Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986762/
https://www.ncbi.nlm.nih.gov/pubmed/36891077
http://dx.doi.org/10.1183/23120541.00417-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986762/
https://www.ncbi.nlm.nih.gov/pubmed/36891077
http://dx.doi.org/10.1183/23120541.00417-2022

Ejemplares similares